Sucampo Pharmaceuticals SCMP (SPI) today announced that
NASDAQ OMX Group, Inc. NDAQ will include the company in the
NASDAQ Biotechnology Index® NBI effective prior to
market open on Monday, May 20, 2013.
The NASDAQ Biotechnology Index is designed to track the performance of a
set of securities listed on The NASDAQ Stock Market that are classified
as either biotechnology or pharmaceutical according to the Industry
Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a
modified market capitalization weighted index. Among the various
criteria that must be met in order to be eligible for inclusion in this
index are a market capitalization of at least $200 million and an
average daily trading
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in